United States Oral Care Products Dental Consumables Market Research Report Information By Product (Dental Restoration Products and Dental Restoration Materials), By End-User (Consumer Stores, Dental Dispensaries, Retail Pharmacies, and Online Distribution), - United States Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. UNITED STATES ORAL CARE PRODUCTS DENTAL CONSUMABLES MARKET, BY PRODUCT

6.1. Overview

6.2. Dental Restoration Products

6.3. Dental Restoration Materials

7. UNITED STATES ORAL CARE PRODUCTS DENTAL CONSUMABLES MARKET, BY END-USER

7.1. Overview

7.2. Consumer Stores

7.3. Dental Dispensaries

7.4. Retail Pharmacies

7.5. Online Distribution

8. COMPETITIVE LANDSCAPE

8.1. Overview

8.2. Competitive Analysis

8.3. Market Share Analysis

8.4. Major Growth Strategy in the United States Oral Care Products Dental Consumables Market,

8.5. Competitive Benchmarking

8.6. Leading Players in Terms of Number of Developments in the United States Oral Care Products Dental Consumables Market,

8.7. Key developments and Growth Strategies

8.7.1. New Product Launch/Service Deployment

8.7.2. Merger & Acquisitions

8.7.3. Joint Ventures

8.8. Major Players Financial Matrix

8.8.1. Sales & Operating Income, 2023

8.8.2. Major Players R&D Expenditure. 2023

9. COMPANY PROFILES

9.1. Institut Straumann AG (Switzerland)

9.1.1. Company Overview

9.1.2. Financial Overview

9.1.3. Products Offered

9.1.4. Key Developments

9.1.5. SWOT Analysis

9.1.6. Key Strategies

9.2. ENVISTA (US)

9.2.1. Company Overview

9.2.2. Financial Overview

9.2.3. Products Offered

9.2.4. Key Developments

9.2.5. SWOT Analysis

9.2.6. Key Strategies

9.3. Dentsply Sirona (US)

9.3.1. Company Overview

9.3.2. Financial Overview

9.3.3. Products Offered

9.3.4. Key Developments

9.3.5. SWOT Analysis

9.3.6. Key Strategies

9.4. 3M (US)

9.4.1. Company Overview

9.4.2. Financial Overview

9.4.3. Products Offered

9.4.4. Key Developments

9.4.5. SWOT Analysis

9.4.6. Key Strategies

9.5. Coltene Holdings AG (Switzerland)

9.5.1. Company Overview

9.5.2. Financial Overview

9.5.3. Products Offered

9.5.4. Key Developments

9.5.5. SWOT Analysis

9.5.6. Key Strategies

9.6. Brasseler USA (US)

9.6.1. Company Overview

9.6.2. Financial Overview

9.6.3. Products Offered

9.6.4. Key Developments

9.6.5. SWOT Analysis

9.6.6. Key Strategies

9.7. NAKANISHI INC. (JAPAN)

9.7.1. Company Overview

9.7.2. Financial Overview

9.7.3. Products Offered

9.7.4. Key Developments

9.7.5. SWOT Analysis

9.7.6. Key Strategies

9.8. BEGO GMBH AND CO. KG (GERMANY)

9.8.1. Company Overview

9.8.2. Financial Overview

9.8.3. Products Offered

9.8.4. Key Developments

9.8.5. SWOT Analysis

9.8.6. Key Strategies

9.9. Young Innovations Inc. (US)

9.9.1. Company Overview

9.9.2. Financial Overview

9.9.3. Products Offered

9.9.4. Key Developments

9.9.5. SWOT Analysis

9.9.6. Key Strategies

9.10. Septodont Holding (France)

9.10.1. Company Overview

9.10.2. Financial Overview

9.10.3. Products Offered

9.10.4. Key Developments

9.10.5. SWOT Analysis

9.10.6. Key Strategies

9.11. Zimmer Biomet (US)

9.11.1. Company Overview

9.11.2. Financial Overview

9.11.3. Products Offered

9.11.4. Key Developments

9.11.5. SWOT Analysis

9.11.6. Key Strategies

9.12. Henry Schein, Inc. (US)

9.12.1. Company Overview

9.12.2. Financial Overview

9.12.3. Products Offered

9.12.4. Key Developments

9.12.5. SWOT Analysis

9.12.6. Key Strategies

9.13. Kuraray Co., Ltd. (Japan)

9.13.1. Company Overview

9.13.2. Financial Overview

9.13.3. Products Offered

9.13.4. Key Developments

9.13.5. SWOT Analysis

9.13.6. Key Strategies

9.14. Geistlich Pharma AG (Switzerland)

9.14.1. Company Overview

9.14.2. Financial Overview

9.14.3. Products Offered

9.14.4. Key Developments

9.14.5. SWOT Analysis

9.14.6. Key Strategies

9.15. Align Technology, Inc. (US)

9.15.1. Company Overview

9.15.2. Financial Overview

9.15.3. Products Offered

9.15.4. Key Developments

9.15.5. SWOT Analysis

9.15.6. Key Strategies

9.16. Ivoclar Vivadent (Liechtenstein)

9.16.1. Company Overview

9.16.2. Financial Overview

9.16.3. Products Offered

9.16.4. Key Developments

9.16.5. SWOT Analysis

9.16.6. Key Strategies

9.17. Mitsui Chemicals Inc. (Japan)

9.17.1. Company Overview

9.17.2. Financial Overview

9.17.3. Products Offered

9.17.4. Key Developments

9.17.5. SWOT Analysis

9.17.6. Key Strategies

9.18. GC Corporation (Japan)

9.18.1. Company Overview

9.18.2. Financial Overview

9.18.3. Products Offered

9.18.4. Key Developments

9.18.5. SWOT Analysis

9.18.6. Key Strategies

9.19. Keystone Dental, Inc. (US)

9.19.1. Company Overview

9.19.2. Financial Overview

9.19.3. Products Offered

9.19.4. Key Developments

9.19.5. SWOT Analysis

9.19.6. Key Strategies

9.20. Ultradent Products, Inc. (US)

9.20.1. Company Overview

9.20.2. Financial Overview

9.20.3. Products Offered

9.20.4. Key Developments

9.20.5. SWOT Analysis

9.20.6. Key Strategies

9.21. OSSTEM Implant Co (Japan)

9.21.1. Company Overview

9.21.2. Financial Overview

9.21.3. Products Offered

9.21.4. Key Developments

9.21.5. SWOT Analysis

9.21.6. Key Strategies

10. APPENDIX

10.1. References

10.2. Related Reports

LIST OF TABLES

TABLE 1 UNITED STATES ORAL CARE PRODUCTS DENTAL CONSUMABLES MARKET, SYNOPSIS, 2019-2032

TABLE 2 UNITED STATES ORAL CARE PRODUCTS DENTAL CONSUMABLES MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 UNITED STATES ORAL CARE PRODUCTS DENTAL CONSUMABLES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 4 UNITED STATES ORAL CARE PRODUCTS DENTAL CONSUMABLES MARKET, BY END-USER, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE UNITED STATES ORAL CARE PRODUCTS DENTAL CONSUMABLES MARKET

FIGURE 3 MARKET DYNAMICS FOR THE UNITED STATES ORAL CARE PRODUCTS DENTAL CONSUMABLES MARKET

FIGURE 4 UNITED STATES ORAL CARE PRODUCTS DENTAL CONSUMABLES MARKET, SHARE (%), BY PRODUCT, 2023

FIGURE 5 UNITED STATES ORAL CARE PRODUCTS DENTAL CONSUMABLES MARKET, SHARE (%), BY END-USER, 2023

FIGURE 6 UNITED STATES ORAL CARE PRODUCTS DENTAL CONSUMABLES MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 7 INSTITUT STRAUMANN AG (SWITZERLAND): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 8 INSTITUT STRAUMANN AG (SWITZERLAND): SWOT ANALYSIS

FIGURE 9 ENVISTA (US: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 10 ENVISTA (US: SWOT ANALYSIS

FIGURE 11 DENTSPLY SIRONA (US: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 12 DENTSPLY SIRONA (US: SWOT ANALYSIS

FIGURE 13 3M (US): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 3M (US): SWOT ANALYSIS

FIGURE 15 COLTENE HOLDINGS AG (SWITZERLAND).: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 COLTENE HOLDINGS AG (SWITZERLAND).: SWOT ANALYSIS

FIGURE 17 BRASSELER USA (US): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 BRASSELER USA (US): SWOT ANALYSIS

FIGURE 19 NAKANISHI INC. (JAPAN): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 NAKANISHI INC. (JAPAN): SWOT ANALYSIS

FIGURE 21 BEGO GMBH AND CO. KG (GERMANY): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 BEGO GMBH AND CO. KG (GERMANY): SWOT ANALYSIS

FIGURE 23 YOUNG INNOVATIONS INC. (US): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 YOUNG INNOVATIONS INC. (US): SWOT ANALYSIS

FIGURE 25 SEPTODONT HOLDING (FRANCE): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 SEPTODONT HOLDING (FRANCE): SWOT ANALYSIS

FIGURE 27 ZIMMER BIOMET (US): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 ZIMMER BIOMET (US): SWOT ANALYSIS

FIGURE 29 HENRY SCHEIN, INC. (US): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 HENRY SCHEIN, INC. (US): SWOT ANALYSIS

FIGURE 31 KURARAY CO., LTD. (JAPAN): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 KURARAY CO., LTD. (JAPAN): SWOT ANALYSIS

FIGURE 33 GEISTLICH PHARMA AG (SWITZERLAND): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 GEISTLICH PHARMA AG (SWITZERLAND): SWOT ANALYSIS

FIGURE 35 ALIGN TECHNOLOGY, INC. (US): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 36 ALIGN TECHNOLOGY, INC. (US): SWOT ANALYSIS

FIGURE 37 IVOCLAR VIVADENT (LIECHTENSTEIN): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 38 IVOCLAR VIVADENT (LIECHTENSTEIN): SWOT ANALYSIS

FIGURE 39 MITSUI CHEMICALS INC. (JAPAN): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 40 MITSUI CHEMICALS INC. (JAPAN): SWOT ANALYSIS

FIGURE 41 GC CORPORATION (JAPAN): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 42 GC CORPORATION (JAPAN): SWOT ANALYSIS

FIGURE 43 KEYSTONE DENTAL, INC. (US): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 44 KEYSTONE DENTAL, INC. (US): SWOT ANALYSIS

FIGURE 45 ULTRADENT PRODUCTS, INC. (US): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 46 ULTRADENT PRODUCTS, INC. (US): SWOT ANALYSIS

FIGURE 47 OSSTEM IMPLANT CO (JAPAN): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 48 OSSTEM IMPLANT CO (JAPAN): SWOT ANALYSIS